What’s available: 3,000 FDA-approved drugs, countless nutriceuticals and 1000s of devices The Problem: 90% of all patients will not see an effective treatment in their lifetime and for 12,000 diseases, only 30-40 new drugs are approved annually What can be done: With 25 research partners, and less than $7M in philanthropic funds, we have created 9 repurposed treatments changing the lives of thousands of patients What can be done: With 25 research partners, and less than $7M in philanthropic funds, we have created 9 repurposed treatments changing the lives of thousands of patients

B Dayton headshot

 

Dr. Brian Dayton is a Senior Research Manager and Drug Discovery and Development Professional specializing in new product development.  He is an accomplished author of peer-reviewed publications and presentations, as well as patents and regulatory submissions.  He is actively involved with Chicago Innovation Mentors, consulting with university-based and local new technology innovation ventures to nurture long term growth in Chicago-based entrepreneurship, innovation and commercialization. 

 

Why is Repurposing important? 

Repurposing101

Sign up for our eNewsletter today!

 

First Name




Cures Within Reach

info@cureswithinreach.org

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.

 

Sunday the 24th. Copyright 2018 Cures Within Reach.